Conference Description:

The Adaptive Clinical Trials Symposium, taking place March 22-23 in Philadelphia, will educate cross-functional stakeholders on the importance of statistics, data management, and operations to improve clinical performance.

Last year, our Interim Analysis Symposium provided attendees with knowledge of best practices to enhance the capacity at which organizations can produce accurate reports to expedite products to market. This year, in response to industry trends and changes, we expanded our reach to encompass all that is adaptive design. Our goal is to inform those involved about how the adaptive design allows for a more proficient use of capital and resources through shorter timeframes and fewer patients.

Join your peers and our esteemed speaking faculty at the only event in the U.S. focused solely on adaptive clinical trials.

Can't-Miss Sessions:

The Platform Trial - An Efficient Approach to Clinical Development of Novel Compounds
Vlad Dragalin, Vice President, Scientific Fellow and Head of Quantitative Sciences Consultancy Group, JANSSEN R And D, USA

Moving Forward: Advancements in Data Collection for Neurological Diseases
Alex Sverdlov, Director, Statistical Scientist, NOVARTIS

In-Depth Look at the Bayesian Method for Adaptive Clinical Trial Design for the Treatment of Alzheimer's Disease
Chad Swanson, Director, Clinical Neuroscience, EISAI

URLs:
Brochure: https://go.evvnt.com/193732-1?pid=154
Booking: https://go.evvnt.com/193732-2?pid=154

Prices:
Early Bird Pricing - Register by February 9, 2018: USD 1895
Standard Pricing: USD 2095
Onsite Pricing: USD 2195

Time: 8:00 am to 6:00 pm